|
1JH5
Crystal Structure of sTALL-1 of TNF family ligand
Deposited 2001-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 60
PDB declaration: 60-meric
|
Chain A
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain B
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain C
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain D
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain E
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain F
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain G
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain H
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain I
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
Chain J
142–285(144 aa)
Fragment:sTALL-1, soluble part of TALL-1
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;35% dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP at 277K
|
Resolution 3.00 Å
R-free 0.252
|
|
1KD7
Crystal structure of an extracellular domain fragment of human BAFF
Deposited 2001-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain B
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain C
122–285(164 aa)
Fragment:Extracellular domain fragment
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;8% PEG 4000, 0.1 M sodium acetatesolution of 8% PEG 4000, 0.1 M sodium acetate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.250
|
|
1KD7
Crystal structure of an extracellular domain fragment of human BAFF
Deposited 2001-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain K
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain L
122–285(164 aa)
Fragment:Extracellular domain fragment
Chain M
122–285(164 aa)
Fragment:Extracellular domain fragment
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;8% PEG 4000, 0.1 M sodium acetatesolution of 8% PEG 4000, 0.1 M sodium acetate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.250
|
|
1KXG
The 2.0 Ang Resolution Structure of BLyS, B Lymphocyte Stimulator.
Deposited 2002-01-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain B
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain C
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
|
Not recorded
|
MG MAGNESIUM ION × 4
CIT CITRIC ACID × 1
DIO 1,4-DIETHYLENE DIOXIDE × 13
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;279 K;25% dioxane, 25 mM MgCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K
|
Resolution 2.00 Å
R-free 0.209
|
|
1KXG
The 2.0 Ang Resolution Structure of BLyS, B Lymphocyte Stimulator.
Deposited 2002-01-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain D
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain E
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
Chain F
134–285(152 aa)
Fragment:soluble portion (residues 134-285)
|
Not recorded
|
MG MAGNESIUM ION × 3
CIT CITRIC ACID × 1
DIO 1,4-DIETHYLENE DIOXIDE × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;279 K;25% dioxane, 25 mM MgCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K
|
Resolution 2.00 Å
R-free 0.209
|
|
1OQD
Crystal structure of sTALL-1 and BCMA
Deposited 2003-03-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 108
PDB declaration: 108-meric
|
Chain A
142–285(144 aa)
Fragment:extracellular domain
Chain B
142–285(144 aa)
Fragment:extracellular domain
Chain C
142–285(144 aa)
Fragment:extracellular domain
Chain D
142–285(144 aa)
Fragment:extracellular domain
Chain E
142–285(144 aa)
Fragment:extracellular domain
Chain F
142–285(144 aa)
Fragment:extracellular domain
Chain G
142–285(144 aa)
Fragment:extracellular domain
Chain H
142–285(144 aa)
Fragment:extracellular domain
Chain I
142–285(144 aa)
Fragment:extracellular domain
Chain J
142–285(144 aa)
Fragment:extracellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.260
|
|
1OQE
Crystal structure of sTALL-1 with BAFF-R
Deposited 2003-03-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 108
PDB declaration: 108-meric
|
Chain A
142–285(144 aa)
Fragment:extracellular domain
Chain B
142–285(144 aa)
Fragment:extracellular domain
Chain C
142–285(144 aa)
Fragment:extracellular domain
Chain D
142–285(144 aa)
Fragment:extracellular domain
Chain E
142–285(144 aa)
Fragment:extracellular domain
Chain F
142–285(144 aa)
Fragment:extracellular domain
Chain G
142–285(144 aa)
Fragment:extracellular domain
Chain H
142–285(144 aa)
Fragment:extracellular domain
Chain I
142–285(144 aa)
Fragment:extracellular domain
Chain J
142–285(144 aa)
Fragment:extracellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 100K
|
Resolution 2.50 Å
R-free 0.259
|
|
1OSG
Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold
Deposited 2003-03-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
82–285(204 aa)
Fragment:TNF domain
Chain B
82–285(204 aa)
Fragment:TNF domain
Chain C
82–285(204 aa)
Fragment:TNF domain
|
Not recorded
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;292 K;20% PEG 3350, 1.0 M LiCl, 0.1M sodium cacodylate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.00 Å
R-free 0.286
|
|
1OSG
Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold
Deposited 2003-03-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
82–285(204 aa)
Fragment:TNF domain
Chain E
82–285(204 aa)
Fragment:TNF domain
Chain F
82–285(204 aa)
Fragment:TNF domain
|
Not recorded
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.7;292 K;20% PEG 3350, 1.0 M LiCl, 0.1M sodium cacodylate, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.00 Å
R-free 0.286
|
|
3V56
Re-refinement of PDB entry 1OSG - Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold - reveals an additonal copy of the peptide.
Deposited 2011-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
82–285(204 aa)
Chain B
82–285(204 aa)
Chain C
82–285(204 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
R-free 0.200
|
|
3V56
Re-refinement of PDB entry 1OSG - Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold - reveals an additonal copy of the peptide.
Deposited 2011-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
82–285(204 aa)
Chain E
82–285(204 aa)
Chain F
82–285(204 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.00 Å
R-free 0.200
|
|
4ZCH
Single-chain human APRIL-BAFF-BAFF Heterotrimer
Deposited 2015-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
140–285(146 aa)
|
Not recorded
|
144 TRIS-HYDROXYMETHYL-METHYL-AMMONIUM × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;RESERVOIR SOLUTION : 14% PEG6000 , 1M LiCL , TRIS-HCL pH 8.50
|
Resolution 2.43 Å
R-free 0.234
|
|
4ZCH
Single-chain human APRIL-BAFF-BAFF Heterotrimer
Deposited 2015-04-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
140–285(146 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;RESERVOIR SOLUTION : 14% PEG6000 , 1M LiCL , TRIS-HCL pH 8.50
|
Resolution 2.43 Å
R-free 0.234
|
|
5Y9J
BAFF in complex with belimumab
Deposited 2017-08-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–285(152 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;0.1 M Tris(hydroxymethyl)aminomethane pH 8.5, 20% (w/v)polyethylene glycol 1,000
|
Resolution 2.05 Å
R-free 0.217
|
|
6FXN
Crystal structure of human BAFF in complex with Fab fragment of anti-BAFF antibody belimumab
Deposited 2018-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
134–285(152 aa)
Chain B
134–285(152 aa)
Chain C
134–285(152 aa)
|
Mutation:H218A
Mutation:H218A
Mutation:H218A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9% (w/v) PEG4000, 0.1 M MgCl2, 0.1 M HEPES pH 7.5
|
Resolution 2.90 Å
R-free 0.231
|
|
6FXN
Crystal structure of human BAFF in complex with Fab fragment of anti-BAFF antibody belimumab
Deposited 2018-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain J
134–285(152 aa)
Chain K
134–285(152 aa)
Chain L
134–285(152 aa)
|
Mutation:H218A
Mutation:H218A
Mutation:H218A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;9% (w/v) PEG4000, 0.1 M MgCl2, 0.1 M HEPES pH 7.5
|
Resolution 2.90 Å
R-free 0.231
|
|
8ZUJ
Pentagonal cluster of BAFF-BAFFR ectodomain complex
Deposited 2024-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain D
134–285(152 aa)
Chain E
134–285(152 aa)
Chain F
134–285(152 aa)
Chain J
134–285(152 aa)
Chain K
134–285(152 aa)
Chain L
134–285(152 aa)
Chain P
134–285(152 aa)
Chain Q
134–285(152 aa)
Chain R
134–285(152 aa)
Chain V
134–285(152 aa)
Chain W
134–285(152 aa)
Chain X
134–285(152 aa)
Chain b
134–285(152 aa)
Chain c
134–285(152 aa)
Chain d
134–285(152 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.58 Å
|